Mylan Inc sells 5.64% stake in Biocon via open market

Ownership Changes View source PDF Explain this filing

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.7%Reaction day

₹436.80

prior close

₹431.00

announcement price

In-mkt

timing

Nifty Midcap 150market-0.0%-0.7% vs market

Pharmaceuticals peers, median of 165sector-0.8%+0.1% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Midcap 150 and 0.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.7-0.0-0.7-0.8+0.1

Next day

-1.2+0.8-2.1+0.3-1.5

-2.5+0.4-2.9-0.7-1.8

-2.5+0.9-3.4-0.3-2.2

-2.2+2.1-4.4+0.3-2.5

-2.6+1.8-4.4+0.7-3.4

-0.0+1.6-1.7+0.3-0.3

15d

-4.4+1.9-6.3+1.1-5.5

-5.5+2.5-8.0+1.6-7.0

-14.2-3.8-10.4+2.4-16.6

-20.2-8.1-12.1-2.0-18.2

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mylan Inc, a US-based shareholder of Biocon Limited, sold 9,19,67,019 equity shares equal to 5.64% of Biocon equity share capital through open market on 14 July 2026. Mylan is not part of the promoter group. The disclosure was filed under SEBI Takeover Regulations 2011.

Likely market impact

Major foreign shareholder exiting a large 5.64% block via open market. May weigh on the stock in the short term.